-
Fyhn Cochrane posted an update 5 days ago
There seems to be no basis for anxiety regarding the application of stress agents in patients who have contracted COVID-19 previously.
A review of randomized controlled trials highlighted a marked increase in the risk of major amputation for patients treated with drug-coated balloons (DCBs), a difference more pronounced with high-dose…[Read more]
-
Fyhn Cochrane posted an update 7 days ago
Extending the capabilities of ConvGNN methods, we seamlessly integrated COPD-related PPI, proteomics, and transcriptomics data to create a predictive model for COPD classification. Compared to conventional classification methods and neural networks that neglect network data, this approach yields higher accuracy. The improved COPD network model,…[Read more]
-
Fyhn Cochrane posted an update 8 days ago
Thirteen patients were found to be positive for COVID-19, and unfortunately, 3 of them died. One death occurred within the first 30 days and two deaths occurred between the first and sixth months.
The first six months of the COVID-19 pandemic in Colombia saw 520 patients requiring hip fracture surgery at 12 different medical centers. A…[Read more]
-
Fyhn Cochrane posted an update 9 days ago
From computational investigations, the solvent’s impact on enantiodivergence was linked to the varying levels of -bond metathesis promoted by neutral and cationic rhodium catalysts.
Analysis of recent data points towards an association between epicardial adipose tissue (EAT) and the manifestation of atrial fibrillation. This study aims to…[Read more]
-